Skip to main content

NIO Inc. Reports Unaudited First Quarter 2025 Financial Results

SHANGHAI, June 03, 2025 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced its unaudited financial results for the first quarter ended March 31, 2025. Operating Highlights for the First Quarter of 2025Vehicle deliveries were 42,094 in the first quarter of 2025, consisting of 27,313 vehicles from the Company’s premium smart electric vehicle brand NIO and 14,781 vehicles from the Company’s family-oriented smart electric vehicle brand ONVO, representing an increase of 40.1% from the first quarter of 2024, and a decrease of 42.1% from the fourth quarter of 2024.Key Operating Results  2025 Q1 2024 Q4 2024 Q3 2024 Q2Deliveries 42,094 72,689 61,855 57,373           2024 Q1 2023 Q4 2023 Q3 2023...

Continue reading

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

Initiation of Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data in 2026 Additional Data from the Ongoing Phase 1b/2 Study of NUC-3373 in Combination with Pembrolizumab Remain on track for 2025 Anticipated Cash Runway Extended into Q4 2026 to Support Key Value-Driving Milestones and Complete the Expansion Study of NUC-7738 EDINBURGH, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ: NCNA) announced financial results for the first quarter ended March 31, 2025 and provided an update on its clinical development program with its two lead anti-cancer medicines. “We have entered 2025 with a clear focus on the advancement of our pipeline through key milestones, into late-stage...

Continue reading

PRESS RELEASE: BIGBEN: FULL YEAR 2024/25 RESULTS

                                              Press release       Lesquin, 2 June 2025 – 6pm CEST FULL YEAR 2024/25 RESULTS:DELAYS TO SEVERAL NEW RELEASES AFFECTED EARNINGS IN 2024/25 BUT WILL LEAD TO STRONG GROWTH IN 2025/26, STARTING IN THE FIRST HALF In its 2 June 2025 meeting, the Board of Directors of Bigben Interactive (ISIN FR0000074072) approved the financial statements for the year ended 31 March 2025. The Statutory Auditors’ report will be issued when the Universal Registration Document is published.Consolidated IFRS figures (€ million) 2024/25 2023/24Sales (IFRS) 288.0 292.0Gross profit% of sales 147.451.2% 142.548.8%EBITDA before non-recurring items% of sales 62.1 62.0Non-recurring items (1.0) 16.0EBITDA 61.1 78.0Operating income(2.0) 23.8Net financial income/(expense)(1.3)(3.6)Profit...

Continue reading

PRESS RELEASE: NACON: FULL YEAR 2024/25 RESULTS

                                                Press release Lesquin, 2 June 2025 – 6pm CEST FULL YEAR 2024/25 RESULTS:DELAYS TO SEVERAL NEW RELEASES AFFECTED EARNINGS IN 2024/25 BUT WILL LEAD TO STRONG GROWTH IN 2025/26, STARTING IN THE FIRST HALF In its 2 June 2025 meeting, the Board of Directors of NACON (ISIN FR0013482791) approved the financial statements for the year ended 31 March 2025. The Statutory Auditors’ report will be issued when the Universal Registration Document is published.Consolidated IFRS figures (€ million) 2024-2025 2023-2024Sales (IFRS) 167.9 167.7Gross profit% of sales 108.164.4% 104.262.1%EBITDA before non-recurring items% of sales 55.933.3% 56.733.8%Non-recurring items (reversal of earn-out provisions) 3.7 14.2EBITDA 59.6 70.9Operating income1.1 20.9Net financial income/(expense)(5.8)(4.8)Profit...

Continue reading

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

ORLANDO, Fla., June 02, 2025 (GLOBE NEWSWIRE) — Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the first quarter ended April 30, 2025. Nutriband is continuing to expand its kinesiology tape output through its Pocono Pharma subsidiary, with a continued focus on penetration pricing to gain a foothold with some of the industry’s largest brands. The Company produced a record first quarter reporting revenue of $667,000USD, up 63% % YOY. Pocono manufactured products continue to roll out into prominent retail locations nationwide, including Target, Walmart, Walgreens and CVS and the increasing Pocono revenue stream is key to the company’s focus on shareholder value. Progress continues on the development of AVERSA Fentanyl, with the Company formalizing an exclusive product development partnership with Kindeva...

Continue reading

Robex Reports Operational and Financial Results for Q1 2025

QUÉBEC CITY, June 02, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company“) (TSXV: RBX/ASX: RXR) Matthew Wilcox, Managing Director, commented: “The company has had a strong start to 2025, construction continues to advance at Kiniero, and we are well positioned for first gold in Q4 2025, meeting both schedule and budget. In parallel, we closed the senior debt facility with Sprott for US$130 million USD in Q1 2025 and progressed our ASX IPO with trading set to commence on 5th June 2025.” CURRENCY Unless otherwise indicated, all references to “$” in this news release are to Canadian dollars. References to “US$” in this news release are to U.S. dollars. KEY PRIORITIES 2025 Delivering the construction project in Guinea as planned: Construction is progressing...

Continue reading

Digi Power X Maintains Strong Cash and Crypto Position With No Long-Term Debt and Reports May 2025 Production Results

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, June 02, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, is pleased to provide unaudited comparative Bitcoin (“BTC”) production results for the month ended May 31, 2025, combined with an operations update. All monetary references are expressed in U.S. dollars unless otherwise indicated. Monthly Production Highlights for May 2025The value of coins produced at the Company’s facilities between its self-mining and colocation agreements and energy sales was approximately $4.3 million in May 2025...

Continue reading

Solar Alliance Energy, Inc. Announces Q1 Earnings, Continued Progress

(figures in Canadian dollars) TORONTO and KNOXVILLE, Tenn., June 02, 2025 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR, OTC: SAENF), a leading solar energy solutions provider focused on the commercial and utility solar sectors, announces it has filed its unaudited financial results for the three months ended March 31, 2025. The Company’s Financial Statements and related Management’s Discussion and Analysis are available under the Company’s profile at www.sedarplus.ca. “Solar Alliance’s main activity in Q1 2025, was the build-out of a large solar energy project for major repeat customer located in Kentucky. Due to unusually severe weather in Kentucky, which included widespread flooding, power outages, and tornadoes throughout the state, the project experienced delays in the quarter....

Continue reading

AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its result for the first quarter of 2025 and its progress towards expansion objectives for the balance of the year. For the three months ended March 31, 2025 the Company realized revenues of $434,061 with a gross profit of $346,297. The Company recorded a comprehensive loss of $77,300 with a net increase in cash of $137,068. Plan the Work – Work the Plan The Company is currently executing its plan to significantly expand HealthTab, its wholly owned turnkey point-of-care testing (POCT) platform that empowers pharmacies to become proactive community diagnostic centers, in the United Kingdom — a decision aligned with the region’s robust healthcare market and significant investment in pharmacy-led...

Continue reading

SAIC Announces First Quarter of Fiscal Year 2026 Results

Revenues of $1.88 billion; approximately 2% revenue growth Net bookings of $2.4 billion; book-to-bill ratio of 1.3 Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues Diluted earnings per share of $1.42; Adjusted diluted earnings per share(1) of $1.92 Cash flows provided by operating activities of $100 million; Free cash flow(1) of $(44) million Management reaffirms fiscal year 2026 guidanceRESTON, Va., June 02, 2025 (GLOBE NEWSWIRE) — Science Applications International Corporation (NASDAQ: SAIC), a premier Fortune 500 technology integrator driving our nation’s digital transformation across the defense, space, civilian, and intelligence markets, today announced results for the first quarter ended May 2, 2025. “Our performance in the first quarter reflects the steady progress we are...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.